Filters & Sorting

What we lose by armchair diagnosing Biden and Trump

Last week, a special counsel report looking into President Biden’s handling of classified documents described the president’s memory as “poor,” with “significant limitations.” Speculation about Biden’s cognitive state immediately followed. In its coverage, Fox News featured a doctor—not Biden’s—who said the president had symptoms of age-related dementia. Also stopping by the network was Republican Sen. Marco Rubio, who said Biden either had dementia or should be charged with a crime. Some Democr

Will California keep funding sickle cell care?

In June 2019, California Gov. Gavin Newsom signed the state’s annual budget into law—which that year included around $15 million (of some $215 billion total) to create and fund a statewide network of treatment centers for sickle cell disease, with training for health workers and improved diagnostic screening. Sickle cell disease, a group of rare genetic disorders characterized by abnormal hemoglobin, can be very painful, cause reduced life expectancy, and involve complications like severe anemi

Congress incentivizes rare disease research. Big Pharma exploits it.

After three years on prednisone, a steroid not recommended for long-term use, Amy G. saw a new specialist. She had been diagnosed with EGPA, a particularly rare type of the autoimmune disorder vasculitis, which causes blood vessels to be inflamed. When it’s not properly managed, people with EGPA—roughly five in every 200,000 adults—risk potentially fatal complications, including bleeding in the lungs. The doctor wanted to start her on Rituximab, a biologic medication that has been found to help.

Our transplant network wastes 25,000 organs a year. We're finally fixing it.

A bipartisan bill to reform the national organ donor network has reached President Joe Biden’s desk, spelling the likely end of a troubled monopoly in place for close to four decades. Signed, the law will let HHS officials, who have commended the changes, award multiple federal contracts to manage the network—part of a wider plan to secure better oversight and more transplants each year.